KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables - Net: 2009-2024

Historic Receivables - Net for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $473.6 million.

  • Idexx Laboratories' Receivables - Net rose 10.88% to $566.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $566.9 million, marking a year-over-year increase of 10.88%. This contributed to the annual value of $473.6 million for FY2024, which is 3.53% up from last year.
  • Latest data reveals that Idexx Laboratories reported Receivables - Net of $473.6 million as of FY2024, which was up 3.53% from $457.4 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Receivables - Net peaked at $473.6 million during FY2024, and registered a low of $331.4 million during FY2020.
  • Moreover, its 3-year median value for Receivables - Net was $457.4 million (2023), whereas its average is $443.9 million.
  • Data for Idexx Laboratories' Receivables - Net shows a peak YoY increased of 23.07% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Idexx Laboratories' Receivables - Net stood at $331.4 million in 2020, then increased by 11.14% to $368.3 million in 2021, then increased by 8.76% to $400.6 million in 2022, then grew by 14.18% to $457.4 million in 2023, then increased by 3.53% to $473.6 million in 2024.